Roche Holding/€ROP

1D1W1MYTD1Y5YMAX

About Roche Holding

Ticker
€ROP
Sector
Health
Primary listing
XGAT
Employees
103,249
Headquarters
Basel, Switzerland
Website
www.roche.com

Roche Holding Metrics

BasicAdvanced
€306B
23.71
€16.20
0.34
-

Bulls say / Bears say

Roche delivered solid underlying momentum in the first half of 2026, with group sales up 6% and core EPS up 9% at constant exchange rates; management maintained its full-year outlook for mid-single-digit sales growth and high-single-digit core EPS growth. (roche.com) (Roche)
The FDA cleared Roche and Eli Lilly’s Elecsys pTau217 Alzheimer’s blood test on August 24, 2026, creating a new diagnostics growth opportunity that can leverage Roche’s installed base of more than 4,500 U.S. cobas instruments. (roche.com) (Reuters)
The pipeline is producing multiple potential catalysts: giredestrant received FDA Priority Review for early-stage breast cancer, while Roche reported positive Phase III divarasib data and continued advancing obesity candidates. (roche.com) (Roche)
A stronger Swiss franc remains a material earnings headwind: first-half 2026 sales fell 2% in reported CHF terms and diluted IFRS EPS declined 8%, despite 6% and 9% growth, respectively, at constant exchange rates. (roche.com) (Reuters)
Vabysmo growth is losing momentum in the United States: Roche reported only 1% U.S. sales growth in the first half, while Reuters said the drug’s U.S. sales missed expectations, increasing execution risk in a major growth franchise. (live.euronext.com) (Reuters)
Legacy-product erosion and weak Chinese diagnostics remain portfolio pressures: products with expired patents declined 8% at constant exchange rates, while diagnostics sales in China fell 9% at constant exchange rates in the first half. (roche.com) (Roche)
Data summarised monthly by Lightyear AI. Last updated on 14 Sept 2026.

Funds containing Roche Holding

AllEURGBPUSD
Funds
Fund name
Fund size
€ROP weighting
Vanguard FTSE Developed Europe ex UK€VERX
€3.4B2.70%
Vanguard FTSE Developed Europe ex UK£VERX
£2.9B2.70%
Xtrackers MSCI Europe£XMEU
£6.7B2.22%
Vanguard FTSE Developed Europe€VWCG
€3.1B2.06%
Vanguard FTSE Developed Europe€VEUR
€4.8B2.06%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.